Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO)

Market Cap	10.74M +14.4%
Revenue (ttm)	10.03M +58.3%
Net Income	736.97K +108.9%
EPS	n/a
Shares Out	8.52M
PE Ratio	14.57
Forward PE	10.50
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,000
Average Volume	32,100
Open	1.260
Previous Close	1.260
Day's Range	1.260 - 1.260
52-Week Range	1.010 - 1.800
Beta	1.28
RSI	61.19
Earnings Date	Apr 14, 2026

About BIT:ERFO

Laboratorio Farmaceutico Erfo S.p.A. engages in the formulation and production of food supplements in Italy. It produces various types of pharmaceutical forms, such as bottles, single-dose vials and bottles, capsules, tablets, and sachets under the Diètnatural and Gianopharma brands, as well as private label brands. The company offers custom formula creation, regulatory advice, graphics, and packaging services. In addition, the company engages in development and franchising of boutique fitness centers. Laboratorio Farmaceutico Erfo S.p.A. was f...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2013
• Employees: 47
• Stock Exchange: Borsa Italiana
• Ticker Symbol: ERFO

Financial Performance

In 2025, BIT:ERFO's revenue was 10.03 million, an increase of 66.31% compared to the previous year's 6.03 million. Earnings were 736,972, an increase of 108.88%.